← Leaderboards
Corey Brelsfoard
Mosquitomate, Inc.
$304,209
Attributed
$304,209
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $201.4K · FY2015–16$250K$187.5K$125K$62.5K$0
'15
'16
Funding mix
By agency
NIH$304,209 · 1
By mechanism
R43$304,209 · 1
Top collaborators
No co-investigators on record.
Most similar at Mosquitomate, Inc.
Same institution · by research overlap
- James William Mains$2,754,636
- Patrick Kelly$597,201
Others in their field
Top investigators on “Adult”
- Lawrence Corey · Fred Hutchinson Cancer Center$594,628,824
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$397,114,680
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$388,038,550
- Judith S. Currier · University Of California Los Angeles$251,592,913
- Kathryn Hirst · Caritas St. Elizabeth'S Medical Center$196,603,707
- Carol Nesel · Westat$188,148,170
Research focus
AdultFaceAffectAnimalsAreaAttentionBaseBehaviorBiteBloodBreedingBusinessesChikungunyaChikungunya VirusCombatCommercializationCulex PipiensCulicidaeDengueDengue VirusDevicesDosageDoseFeeding
Grant awards (2)
Feasibility assessment of a novel tool for mosquito vector control: Auto-Dissemination Augmented by Males (ADAM)$102,783
R43 · FY2016 · AI · contact PI
Feasibility assessment of a novel tool for mosquito vector control: Auto-Dissemination Augmented by Males (ADAM)$201,426
R43 · FY2015 · AI · contact PI